Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2003
10/23/2003CA2481747A1 Recombinant anti-interleukin-9 antibodies
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/22/2003EP1354959A1 Process for producing recombinant protein and fused protein
10/22/2003EP1354894A2 Fusion peptide of human type-1 collagen derived peptide and tat peptide, preparation thereof, and skin anti-aging cosmetic composition comprising the same
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354204A2 Hcv antigen/antibody combination assay
10/22/2003EP1354196A2 Diagnostics, drug screening and treatment for cancer
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354033A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353942A2 Peptide inhibitors of hiv entry
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP0659217B1 CLONING AND EXPRESSION OF beta APP-C100 RECEPTOR
10/22/2003CN1451038A Attenuated influenza virus useful as vaccine
10/22/2003CN1450087A Recombinant Toxoplasma fusion protein antigen and preparation process and use thereof
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125084C Thrombolytic fusion protein targeting thrombus
10/21/2003US6635748 Protein for use as antitumor agent; for use as antimetastsis agent
10/21/2003US6635740 Ligand/lytic peptide compositions and methods of use
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635429 Incubating a cell containing sequence linked to a DNA response element with an agent to determine its capability of transactivating the sequence; retinoic acid, thyroid, retinoid X
10/21/2003US6635256 Administering multiple domain glycoprotein hormones containing alpha subunit covalently linked to beta subunit to form single chain hormone and additional beta subunit noncovalently linked to tethered alpha subunit of single chain hormone
10/21/2003US6635248 Isolated polypeptide consisting of single chain of amino acids comprising one or more penetrating fragments from one or more penetrating antibodies, which penetrates into cell
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003084996A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003059935A3 Methods for purifying protein
10/16/2003WO2003056017A3 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease
10/16/2003WO2003046560B1 Self-assembly molecules
10/16/2003WO2003016472A3 Hybrid interferon/interferon tau proteins, compositions and methods of use
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003010192A3 An inducer of apoptosis
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195154 Comprises mimetics of erythropoietin, thrombopoietin, and glucagon-like peptide conjugated to polymer
10/16/2003US20030195146 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages
10/16/2003US20030194737 Use of parapox B2L protein to modify immune responses to administered antigens
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194695 Nucleic acid and polypeptide sequences useful as adjuvants
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003US20030194391 Vaccine
10/16/2003CA2779639A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2481829A1 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/15/2003EP1352070A2 A fibrin/fibrinogen-binding conjugate
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1351990A2 Compositions and methods for detecting proteolytic activity
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351708A1 Therapeutic agent comprising a b-subunit of a protein toxin
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449250A Novel insecticidal toxins derived from bacillus thuringiensis insecticidal crystal proteins
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/14/2003US6632928 Immunotoxins and methods of inducing immune tolerance
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632601 Immunoassays for anti-HCV antibodies
10/14/2003US6632440 Chronic obstructive pulmonary disease (COPD), asthma; Aerosol administration a compound that inhibits exocytosis in mucus secreting cells produced by modifying a clostridial neurotoxin
10/14/2003US6632426 G-CSF analog compositions and methods
10/09/2003WO2003083104A1 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made thereform
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082910A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
10/09/2003WO2003082346A1 Recombinant chimeric protein for the target delivery of dna to eukariotic target cells
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191056 Immobilization onto polyoxyethylene glycol
10/09/2003US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis
10/09/2003US20030190674 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
10/09/2003US20030190651 Preventing, ameliorating, correcting dysfunctions or diseases such as cancer, peripheral and central nervous system diseases, and chronic obstructive pulmonary disease
10/09/2003US20030190614 Non-human primate Fc receptors and methods of use
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190285 Having nucleotide sequence of any one of the strands of any one of the members of the High Mobility Group protein genes or LIM protein genes, including modified versions and derivatives thereof; diagnostic and therapeutic applications
10/09/2003CA2480319A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/08/2003EP1350105A2 Immunoassays for anti-hcv antibodies
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349868A1 Process to concentrate insoluble proteins by vibrating membrane filtration
10/08/2003EP1349569A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 295